A.P. Hall

EGFR Antagonists in Cancer Treatment

Beneficial Therapeutic Effect of Plasmapheresis After Unsuccessful Treatment With Corticosteroids in Two Patients With Severe Toxic Epidermal Necrolysis

Novel interferon-γ enzyme-linked immunoSpot assay using activated cells for identifying hypersensitivity-inducing drug culprits

Toxic epidermal necrolysis: Review of pathogenesis and management

TFOS DEWS II pathophysiology report

Placement of ProKera in the Management of Ocular Manifestations of Acute Stevens-Johnson Syndrome in an Outpatient

Toxic epidermal necrolysis (Lyell's disease)

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

Toxic epidermal necrolysis

TFOS DEWS II Management and Therapy Report

Mechanisms of cutaneous toxicities to EGFR inhibitors

The Effect of Remifentanil on the Bispectral Index Change and Hemodynamic Responses After Orotracheal Intubation

Prediction of difficult tracheal intubation

Amniotic Membrane Transplantation as a New Therapy for the Acute Ocular Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

The predominant drug-specific T-cell population may switch from cytotoxic T cells to regulatory T cells during the course of anticonvulsant-induced hypersensitivity

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Supportive Therapy for a Patient With Toxic Epidermal Necrolysis Undergoing Plasmapheresis

Predicting Difficult Intubation in Apparently Normal Patients

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.

Review of Toxic Epidermal Necrolysis

Toxic epidermal necrolysis: current evidence, practical management and future directions

Effect of remifentanil on the haemodynamic response to orotracheal intubation